Personalis Inc (PSNL)
5.50
+0.50
(+10.00%)
USD |
NASDAQ |
Nov 05, 14:32
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 291.91M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 346.4% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 3.460 |
Price to Book Value | 2.600 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.0203 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 98.18% |
Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. |
URL | https://www.personalis.com |
Investor Relations URL | https://investors.personalis.com/ |
HQ State/Province | California |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Small Cap/Value |
Next Earnings Release | Nov. 06, 2024 |
Last Earnings Release | Aug. 07, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. |
URL | https://www.personalis.com |
Investor Relations URL | https://investors.personalis.com/ |
HQ State/Province | California |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Small Cap/Value |
Next Earnings Release | Nov. 06, 2024 |
Last Earnings Release | Aug. 07, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |